Development of Acquired Resistance in Alpelisib-treated Gastric Cancer Cells With<i>PIK3CA</i>Mutations and Overcoming StrategiesMingu Kang(Seoul National University), Keun‐Wook Lee(Seoul National University Bundang Hospital)Anticancer ResearchApril 28, 202510.21873/anticanres.17567Cited by 1SaveCiteExport RISWatch citationsRelated PapersAmphiregulin can predict treatment resistance to palliative first-line cetuximab plus FOLFIRI chemotherapy in patients with RAS wild-type metastatic colorectal cancer|Scientific Reports|2021|20AZD8186 in Combination With Paclitaxel in Patients With Advanced Gastric Cancer: Results From a Phase Ib/II Study (KCSG ST18-20)|The Oncologist|2023|19